"10.1371_journal.pone.0095694","plos one","2014-04-21T00:00:00Z","Halesha D Basavarajappa; Bit Lee; Xiang Fei; Daesung Lim; Breedge Callaghan; Julie A Mund; Jamie Case; Gangaraju Rajashekhar; Seung-Yong Seo; Timothy W Corson","Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; College of Pharmacy, Gachon University, Incheon, South Korea; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States Of America; Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America","Conceived and designed the experiments: HDB BL XF GR S-YS TWC. Performed the experiments: HDB BL XF DL BC JAM JC GR S-YS TWC. Analyzed the data: HDB JAM GR S-YS TWC. Wrote the paper: HDB BL XF DL BC JAM JC GR S-YS TWC.","HDB, BL, XF, S-YS, and TWC are named on a patent application disclosing the synthesis and antiangiogenic applications of the molecule described in this manuscript. HDB was supported by a scholarship from Kemin Health. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","04","Halesha D Basavarajappa","HDB",10,TRUE,6,10,5,10,TRUE,TRUE,FALSE,0,NA,FALSE
